(S)-N-(4-(((2S,5R)-5-((R)-Hydroxy(phenyl)methyl)pyrrolidin-2-yl)-methyl)phenyl)-2-(6-oxopyridazin-1(6H)-yl)propanamide

ID: ALA3765335

PubChem CID: 127037832

Max Phase: Preclinical

Molecular Formula: C25H28N4O3

Molecular Weight: 432.52

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  C[C@@H](C(=O)Nc1ccc(C[C@@H]2CC[C@H]([C@H](O)c3ccccc3)N2)cc1)n1ncccc1=O

Standard InChI:  InChI=1S/C25H28N4O3/c1-17(29-23(30)8-5-15-26-29)25(32)28-20-11-9-18(10-12-20)16-21-13-14-22(27-21)24(31)19-6-3-2-4-7-19/h2-12,15,17,21-22,24,27,31H,13-14,16H2,1H3,(H,28,32)/t17-,21-,22+,24+/m0/s1

Standard InChI Key:  PBXGYXYBIGMVQD-KBABAZTHSA-N

Molfile:  

     RDKit          2D

 33 36  0  0  0  0  0  0  0  0999 V2000
    1.2990   -0.7500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2990    0.7500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    1.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2990    0.7500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2990   -0.7500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000   -1.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5972   -1.5031    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5951   -3.0039    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6375   -0.9049    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2809   -2.3599    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2755   -3.4730    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0234   -4.7733    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4911   -4.4637    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4090   -6.1397    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0841   -6.2921    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7012   -7.6593    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1938   -7.8085    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0693   -6.5906    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4523   -5.2233    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9597   -5.0741    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5630   -6.7368    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.4373   -5.5169    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9417   -4.4240    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4603   -3.5054    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    7.9309   -5.6632    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8052   -4.4433    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.1835   -3.0781    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.0548   -1.8571    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2983   -4.5873    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7957   -5.6793    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.1696   -3.3663    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5479   -2.0012    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4265   -6.7561    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  5  7  1  0
  7  8  1  0
  7  9  1  6
  8 10  1  0
 10 11  1  0
 12 11  1  0
 12 13  1  0
 13  8  1  0
 12 14  1  1
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 15  1  0
 18 21  1  0
 21 22  1  0
 22 23  2  0
  8 24  1  6
 22 25  1  0
 25 26  1  0
 26 27  1  0
 26 29  1  0
 27 28  2  0
 28 32  1  0
 31 29  1  0
 29 30  2  0
 31 32  2  0
 25 33  1  1
M  END

Alternative Forms

  1. Parent:

    ALA3765335

    ---

Associated Targets(Human)

ADRB3 Tclin Beta-3 adrenergic receptor (5850 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRB1 Tclin Beta-1 adrenergic receptor (6630 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRB2 Tclin Beta-2 adrenergic receptor (11824 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KCNH2 Tclin HERG (29587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CACNA1C Tclin Voltage-gated L-type calcium channel alpha-1C subunit (766 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SCN5A Tclin Sodium channel protein type V alpha subunit (3462 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC6A4 Tclin Serotonin transporter (12625 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HepG2 (196354 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Liver microsome (8277 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasma (7708 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Canis familiaris (36305 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rhesus monkey (3147 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Liver microsome (4459 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Liver microsome (341 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasma (10718 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasma (810 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasma (280 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Adrb3 Beta-3 adrenergic receptor (328 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRB3 Beta-3 adrenergic receptor (22 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRB3 Beta-3 adrenergic receptor (63 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
UGT2B9 UDP-glucuronosyltransferase 2B9 (4 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 432.52Molecular Weight (Monoisotopic): 432.2161AlogP: 2.84#Rotatable Bonds: 7
Polar Surface Area: 96.25Molecular Species: BASEHBA: 6HBD: 3
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 12.55CX Basic pKa: 10.61CX LogP: 2.62CX LogD: -0.31
Aromatic Rings: 3Heavy Atoms: 32QED Weighted: 0.53Np Likeness Score: -0.57

References

1. Edmondson SD, Zhu C, Kar NF, Di Salvo J, Nagabukuro H, Sacre-Salem B, Dingley K, Berger R, Goble SD, Morriello G, Harper B, Moyes CR, Shen DM, Wang L, Ball R, Fitzmaurice A, Frenkl T, Gichuru LN, Ha S, Hurley AL, Jochnowitz N, Levorse D, Mistry S, Miller RR, Ormes J, Salituro GM, Sanfiz A, Stevenson AS, Villa K, Zamlynny B, Green S, Struthers M, Weber AE..  (2016)  Discovery of Vibegron: A Potent and Selective β3 Adrenergic Receptor Agonist for the Treatment of Overactive Bladder.,  59  (2): [PMID:26709102] [10.1021/acs.jmedchem.5b01372]

Source